Quotables
"The production of too many useful things results in too many useless people."
Karl Marx
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8188066 | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors Novel methods for the medical treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded animals including humans involving administration of selective estrogen r... | 05/29/2012 |
| 8168620 | Combination of azelastine and steroids A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutically acceptable salt, solvate or physiologically functional derivativ... | 05/01/2012 |
| 8163723 | Combination of azelastine and steroids A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative ... | 04/24/2012 |
| 8119620 | Dosage form for hormonal contraception A dosage form for hormonal contraception containing a specific number of gestagen-containing daily units A and a specific number of gestagen-containing daily units B for uninterrupted, daily, oral administration of daily units A and then immediately subsequently of ... | 02/21/2012 |
| 8119621 | Tetrahydro-cyclopentyl pyrazole cannabinoid modulators This invention is directed to a tetrahydro-cyclopentyl pyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder ... | 02/21/2012 |
| 8097605 | Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory disease The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R,R-glycopyrrolate, for symptomatic or proph... | 01/17/2012 |
| 8084444 | Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations Dermatitis can be effectively treated with the combined administration of dehydroepiandrosterone (DHEA) and a glucocorticoid. Systemic, topical and prepackaged DHEA-glucocorticoid embodiments are described. ... | 12/27/2011 |
| 8084445 | Pharmaceutical formulation Disclosed are novel formulations for the treatment of otic infections in an animal comprising a triazole anti-fungal compound, a quinolone antibiotic and a corticosteroid such as mometasone furoate monohydrate. ... | 12/27/2011 |
| 8076317 | Contraception process and administration form for the same Process for hormonal contraception, in which in a plurality of substantially time-unlimited, linked taking periods and optionally having a sequence lasting several years and which in each case comprise at least one taking cycle with a duration-constant taking phase ... | 12/13/2011 |
| 8076318 | Caged ligands and uses thereof Provided are caged compounds comprising a ligand that specifically reacts with a receptor not naturally present in mammals. The cage is released from the ligand upon illumination of the compound with light. Also provided are cells transfected with a gene of interest... | 12/13/2011 |
| 8076319 | Treatment of conditions relating to hormone deficiencies by administration of progestins The present invention includes methods for preventing endometrial hyperplasia associated with estrogen therapy through the administration of a progestin agent. The methods presented may include starting the administration of a progestin agent at a high dose, and the... | 12/13/2011 |
| 8071578 | Tazarotene and corticosteroid treatment for psoriasis The present invention provides a method for treating proliferative skin diseases comprising the administration of an effective amount of tazarotene and an effective amount of a corticosteroid. This invention is especially useful for treating psoriasis. ... | 12/06/2011 |
| 8048869 | Pharmaceutical composition for use in hormone replacement therapy One aspect of the invention is concerned with a method of hormone replacement therapy, which method comprises administering to a person in need of such a therapy an effective amount of an estrogenic component selected from the group consisting of: substances represe... | 11/01/2011 |
| 8030296 | Oestrogen-17-sulphamates as inhibitors of steroid sulphatase There is provided a compound of Formula I wherein X is a ring system; R1 is any one of a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group; R2 i... | 10/04/2011 |
| 7989436 | Estrogenic compounds and pharmaceutical formulations comprising the same Novel estrogenic compounds of Formula I are provided. wherein the bond represented by the wavy line may be a single or double bond such that when the wavy line is a single bond, R1 is selected from the group cons... | 08/02/2011 |
| 7968531 | Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis The invention relates to the use of 2,5-dihydroxybenzenesulfonic acid in the production of medicaments for the treatment of angiodependent diseases. More specifically, the invention relates to the use of the aforesaid compound and, in particular, the calcium and pot... | 06/28/2011 |
| 7943602 | Pharmaceutical application of 15- or 16-substituted testosterone analogues The invention relates to pharmaceutical dosage units for oral, transmucosal or transdermal administration containing 15- or 16-substituted testosterone analogues, as well as to therapeutic methods that employ these testosterone analogues. More particularly, the inve... | 05/17/2011 |
| 7939515 | Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy Topical application of a triple combination immixture of fluocinolone acetonide, tretinoin and hydroquinone is useful for the maintenance therapy of melasma to prevent hyperpigmentation recurrence or reduce the severity of the hyperpigmentation recurrence. ... | 05/10/2011 |
| 7939514 | Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy Topical application of a triple combination immixture of fluocinolone acetonide, tretinoin and hydroquinone is useful for the maintenance therapy of melasma to prevent hyperpigmentation recurrence or reduce the severity of the hyperpigmentation recurrence. ... | 05/10/2011 |
| 7923441 | Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application Methods and compositions for enhancing the activity and/or duration of action of loteprednol etabonate and other soft anti-inflammatory steroids of the haloalkyl 17α-alkoxycarbonyloxy-11β-hydroxyandrost-4-en-3-one-17β-carboxylate type and the corresponding Δ | 04/12/2011 |
| 7902177 | Treatment of congestion using steroids and adrenergics A decongestant composition is provided comprising: (a) a safe and effective amount of an adrenergic compound; (b) a safe and effective amount of a steroid; and (c) a pharmaceutically-acceptable carrier. Methods of treating congestion in a human or animal subject are... | 03/08/2011 |
| 7884091 | Methods for treating delirium using glucocorticoid receptor-specific antagonists This invention generally pertains to the field of psychiatry. In particular, this invention pertains to the discovery that agents which inhibit the binding of cortisol to its receptors can be used in methods for treating delirium. Mifepristone, a potent specific glu... | 02/08/2011 |
| 7884092 | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors Novel methods for the medical treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded animals including humans involving administration of selective estrogen r... | 02/08/2011 |
| 7879833 | Combination medicament The invention relates to the combination of ciclesonide with formoterol. ... | 02/01/2011 |
| 7879831 | Enhanced drug delivery in transdermal systems A composition for transdermal administration resulting from an admixture includes: a therapeutically effective amount of a pharmaceutically active agent that includes a corresponding steroid and a steroid derivative; and a carrier for the pharmaceutically active age... | 02/01/2011 |
| 7879832 | Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis The present invention relates to a combination of ciclesonide with antihistamines. ... | 02/01/2011 |
| 7871995 | Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception A method of contraception in mammalian females, which method comprises the parenteral or rectal administration of an estrogenic component and a progestogenic component to a female of childbearing capability in an amount effective to inhibit ovulation, wherein the es... | 01/18/2011 |
| 7867986 | Enhanced drug delivery in transdermal systems A composition for transdermal administration resulting from an admixture includes: a therapeutically effective amount of a pharmaceutically active agent that includes a corresponding steroid and a steroid derivative; and a carrier for the pharmaceutically active age... | 01/11/2011 |
| 7867987 | Medicaments for inhalation comprising an anticholinergic and a steroid A pharmaceutical composition comprising a compound of formula 1 wherein X− is an anion with a single negative charge, and a betamimetic, optionally together with a pharmaceutically acceptable excipient, the com... | 01/11/2011 |
| 7846916 | Enhanced drug delivery in transdermal systems A composition for transdermal administration resulting from an admixture includes: a therapeutically effective amount of a pharmaceutically active agent that includes a corresponding steroid and a steroid derivative; and a carrier for the pharmaceutically active age... | 12/07/2010 |
| 7825107 | Method of treating men suffering from chronic nonbacterial prostatitis with SERM compounds or aromatase inhibitors A method for treatment or prevention of chronic nonbacterial prostatitis in individuals without urethral sphincter dysfunction, comprises administering an effective amount of (i) a selective estrogen receptor modulator (SERM) having estrogen antagonist effect in the... | 11/02/2010 |
| 7812010 | Pharmaceutical preparations for treatments of diseases and disorders of the breast Formulations for topical or local administration of drugs directly to the breast or chest to produce a regional or local effect with lower systemic drug levels than when an effective amount is administered systemically are disclosed herein. In a preferred embodiment... | 10/12/2010 |
| 7812009 | Mastitis treatment A pharmaceutical composition for intramammary administration to a nonhuman mammal comprising an antibacterial agent and prednisolone, wherein the composition comprises at least 20 mg of prednisolone, and its use for the treatment of clinical mastitis. ... | 10/12/2010 |
| 7772220 | Methods and compositions for reducing toxicity of a pharmaceutical compound The present disclosure is related to clear aqueous solutions of one or more bile acids and either an aqueous soluble starch conversion product or a non-starch polysaccharide. Solutions of the disclosure may be administered to a subject in conjunction with a pharmace... | 08/10/2010 |
| 7723320 | Use of estrogen compounds to increase libido in women Disclosed is a method of increasing libido in a woman, said method comprising administering to said woman an effective amount of an estrogenic component selected from the group consisting of: substances represented by the following formula (I) in which formula R | 05/25/2010 |
| 7687485 | Formulation for menopausal women The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from symptoms associated with menopause, as well as prophylactic effects, and methods for using same. ... | 03/30/2010 |
| 7683046 | Benzodiazepine compositions for treating epidermal hyperplasia and related disorders The present invention provides, for example, pharmaceutical compositions comprising a benzodiazepine compound and an agent selected from the group consisting of a topical steroid, a keratolytic agent, a topical retinoid, a coal tar, and a vitamin D-3 analog. The pha... | 03/23/2010 |
| 7683047 | Treatment of conditions relating to hormone deficiencies by administration of progestins The present invention includes methods for preventing endometrial hyperplasia associated with estrogen therapy through the administration of a progestin agent. The methods presented may include starting the administration of a progestin agent at a high dose, and the... | 03/23/2010 |
| 7671044 | Pharmaceutical formula for treating skin disease The present invention refers to a pharmaceutical formulation characterized in that it includes mainly clobetasolpropionate, minoxidil and 11 alpha hydroxyprogesterone as main active principles, besides other excipients, vitamins and/or minerals, and to its use in th... | 03/02/2010 |
| 7666859 | Skin compositions containing hydrocortisone Skin compositions comprising, hydrocortisone; allantoin; and a water-based vehicle that is essentially free of petroleum jelly, mineral oil and wax; and related method for protecting, healing and/or soothing the skin comprising: applying an effective amount of a cos... | 02/23/2010 |
